AGLE - Aeglea BioTherapeutics EPS beats by $0.11 November, 05 2020 08:38 AM Aeglea BioTherapeutics Inc. Aeglea BioTherapeutics (AGLE): Q3 GAAP EPS of -$0.29 beats by $0.11.Cash, cash equivalents, marketable securities and restricted cash of $141.5M.Press Release For further details see: Aeglea BioTherapeutics EPS beats by $0.11